The global High Throughput Screening (HTS) Market is poised for sustained expansion through 2025–2032 as biopharmaceutical companies, CROs, and academic centers accelerate discovery pipelines, compress lead‐identification timelines, and expand phenotypic and target-based screening programs. Driven by automation advances, miniaturized assay formats, AI-assisted hit triage, and...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt